Targeting Intracellular Mycobacteria Using Nanosized Niosomes Loaded with Antibacterial Agents.

Nanoniosomes improved drug efficacy while decreasing toxicity and should be considered for further testing in the treatment of intracellular pathogenic mycobacteria or as a new platform for precise intracellular delivery of drugs.